Wenyan Hao

机构：Peking University, Peking University First Hospital, Luye Pharma (China), Institute of Pharmacology, Jiangxi Normal University · ORCID：0000-0003-1430-6003

发表论文 129 篇 · 总被引 1552 次 · h-index 23

代表论文

• Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma (2021 · Bioactive Materials · 被引 125)
• Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery (2021 · Journal of Nanobiotechnology · 被引 79)
• PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer (2021 · Nature Communications · 被引 46)
• Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma (2021 · Molecules · 被引 44)
• Immunomodulatory Nanozymes Eradicate Intracellular Infections and Rescue Immunoparalysis for Treating Multidrug‐Resistant Bacterial Sepsis (2025 · Exploration · 被引 26)
• Targeted Ferroptosis-Immunotherapy Synergy: Enhanced Antiglioma Efficacy with Hybrid Nanovesicles Comprising NK Cell-Derived Exosomes and RSL3-Loaded Liposomes (2024 · ACS Applied Materials & Interfaces · 被引 23)